Open AccessApatinib plus 5-fluorouracil as a third or subsequent-line treatment option for metastatic colorectal cancer: a phase-II, single-arm, prospective study
Author(s) -
Runzhi Chen,
Yang Liu,
Sheng Hu,
Zhusheng Yin,
Yanli Nie,
Hongli Xu,
Yi Zhong,
Yuze Zhu,
Xinjun Liang,
Huiting Xu
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-77
Subject(s) - medicine , apatinib , capecitabine , gastroenterology , colorectal cancer , tegafur , phases of clinical research , progression free survival , adverse effect , progressive disease , oncology , surgery , cancer , toxicity , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom